Last 12 months
Inside the activity.
6 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 3 |
| Apr 2026 | 2 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2025 Filed Jun 27, 2025 21:36 UTC |
Munson GillianDirector
|
GrantCommon Stock | 6,700 | $27.61 | $184,987.00 |
DisclosureSEC source: 0001127602-25-018181 · form4.xml · nonDerivative · entry 1 Munson Gillian · CIK 0001592494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,174 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 25, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (a) 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (b) five years from the date of grant of the deferred RSUs. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:54 UTC |
Goldstein LainieDirector
|
GrantCommon Stock | 6,700 | $27.61 | $184,987.00 |
DisclosureSEC source: 0001127602-25-018184 · form4.xml · nonDerivative · entry 1 Goldstein Lainie · CIK 0001399513 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,555 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 25, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:34 UTC |
Sayar RaminDirector
|
GrantCommon Stock | 6,700 | $27.61 | $184,987.00 |
DisclosureSEC source: 0001127602-25-018180 · form4.xml · nonDerivative · entry 1 Sayar Ramin · CIK 0001822614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,435 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 25, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:49 UTC |
Linetsky DavidSVP, Network Solutions
|
SaleCommon Stock | 67 | $25.61 | $1,715.96 |
DisclosureSEC source: 0001412408-25-000044 · form4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Network Solutions 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,795 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.255 to $25.935 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:49 UTC |
Linetsky DavidSVP, Network Solutions
|
SaleCommon Stock | 42 | $25.17 | $1,057.23 |
DisclosureSEC source: 0001412408-25-000044 · form4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Network Solutions 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,862 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.68 to $25.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:18 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 582 | $28.00 | $16,296.00 |
DisclosureSEC source: 0001127602-25-017302 · form4.xml · nonDerivative · entry 1 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,010 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 16, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 17:21 UTC |
Weintraub MichaelDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,569 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001127602-25-017304 · form4.xml · derivative · entry 8 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,887 Underlying: Common Stock · 2,569 shares Expires 2028-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 17:21 UTC |
Weintraub MichaelDirector
|
SaleCommon Stock | 2,569 | $27.86 | $71,567.72 |
DisclosureSEC source: 0001127602-25-017304 · form4.xml · nonDerivative · entry 4 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,039 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $28.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Reflects certain transfers made from the GRAT (defined below) to the Reporting Person. Such transfers were exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 17:21 UTC |
Weintraub MichaelDirector
|
Exercise / conversionCommon Stock | 2,569 | $4.71 | $12,099.99 |
DisclosureSEC source: 0001127602-25-017304 · form4.xml · nonDerivative · entry 3 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. F2 · balance_after: Reflects certain transfers made from the GRAT (defined below) to the Reporting Person. Such transfers were exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 17:21 UTC |
Weintraub MichaelDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,431 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001127602-25-017304 · form4.xml · derivative · entry 7 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,456 Underlying: Common Stock · 7,431 shares Expires 2028-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 17:21 UTC |
Weintraub MichaelDirector
|
SaleCommon Stock | 7,431 | $27.51 | $204,443.90 |
DisclosureSEC source: 0001127602-25-017304 · form4.xml · nonDerivative · entry 2 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,039 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Reflects certain transfers made from the GRAT (defined below) to the Reporting Person. Such transfers were exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 17:21 UTC |
Weintraub MichaelDirector
|
Exercise / conversionCommon Stock | 7,431 | $4.71 | $35,000.01 |
DisclosureSEC source: 0001127602-25-017304 · form4.xml · nonDerivative · entry 1 Weintraub Michael · CIK 0001776800 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. F2 · balance_after: Reflects certain transfers made from the GRAT (defined below) to the Reporting Person. Such transfers were exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 15, 2025 Filed May 16, 2025 21:02 UTC |
Hui YvonnePrincipal Accounting Officer
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014768 · form4.xml · nonDerivative · entry 1 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,592 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest as follows: 10% of the RSUs shall vest on May 15, 2026, 20% of the RSUs shall vest on May 15, 2027, 30% of the RSUs shall vest on May 15, 2028 and 40% of the RSUs shall vest on May 15, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 22:12 UTC |
CAHILL EDWARD LDirector
|
GrantCommon Stock | 400 | $24.96 | $9,984.00 |
DisclosureSEC source: 0001127602-25-013271 · form4.xml · nonDerivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,273 F1 · shares: Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of the Issuer and incurring a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (ii) five years from the date of grant of the DSUs. Read SEC document |
| April 30, 2025 Filed May 2, 2025 22:14 UTC |
Munson GillianDirector
|
GrantCommon Stock | 400 | $24.96 | $9,984.00 |
DisclosureSEC source: 0001127602-25-013273 · form4.xml · nonDerivative · entry 1 Munson Gillian · CIK 0001592494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,474 F1 · shares: Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of the Issuer and incurring a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (ii) five years from the date of grant of the DSUs. Read SEC document |
| April 30, 2025 Filed May 2, 2025 22:13 UTC |
Goldstein LainieDirector
|
GrantCommon Stock | 400 | $24.96 | $9,984.00 |
DisclosureSEC source: 0001127602-25-013272 · form4.xml · nonDerivative · entry 1 Goldstein Lainie · CIK 0001399513 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,855 F1 · shares: Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 20:15 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 1,330 | $23.70 | $31,521.00 |
DisclosureSEC source: 0001127602-25-012492 · form4.xml · nonDerivative · entry 2 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,592 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 16, 2024. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:15 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 993 | $23.04 | $22,880.51 |
DisclosureSEC source: 0001127602-25-012492 · form4.xml · nonDerivative · entry 1 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,922 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 to $23.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:24 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 260 | $23.04 | $5,990.87 |
DisclosureSEC source: 0001127602-25-012493 · form4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 8,752 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 to $23.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 21:00 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 418 | $23.66 | $9,889.88 |
DisclosureSEC source: 0001127602-25-012304 · form4.xml · nonDerivative · entry 2 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,915 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 16, 2024. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 21:05 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 2,488 | $23.66 | $58,866.08 |
DisclosureSEC source: 0001127602-25-012308 · form4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,239 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 15, 2025. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 21:05 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 2,011 | $23.81 | $47,876.28 |
DisclosureSEC source: 0001127602-25-012308 · form4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,727 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.39 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 21:02 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 624 | $23.81 | $14,855.69 |
DisclosureSEC source: 0001127602-25-012307 · form4.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,820 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.49 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 21:01 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 1,845 | $23.81 | $43,924.28 |
DisclosureSEC source: 0001127602-25-012306 · form4.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774,807 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.49 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 20:59 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 1,213 | $23.81 | $28,878.13 |
DisclosureSEC source: 0001127602-25-012303 · form4.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,921 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.49 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 21:00 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 3,091 | $23.81 | $73,588.06 |
DisclosureSEC source: 0001127602-25-012305 · form4.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,254,574 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.49 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2025 Filed Apr 17, 2025 20:58 UTC |
Gandhi BalajiChief Financial Officer
|
SaleCommon Stock | 864 | $23.81 | $20,569.42 |
DisclosureSEC source: 0001127602-25-012302 · form4.xml · nonDerivative · entry 1 Gandhi Balaji · CIK 0001970527 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,547 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.49 to $24.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 21:00 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 314 | $24.04 | $7,549.56 |
DisclosureSEC source: 0001127602-25-012304 · form4.xml · nonDerivative · entry 1 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,333 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.53 to $24.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 00:55 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 2,802 | $23.23 | $65,090.46 |
DisclosureSEC source: 0001127602-25-011936 · form4.xml · nonDerivative · entry 3 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,647 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 16, 2024. Read SEC document |
| April 09, 2025 Filed Apr 11, 2025 00:55 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 4,696 | $23.23 | $109,088.08 |
DisclosureSEC source: 0001127602-25-011935 · form4.xml · nonDerivative · entry 3 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,134 F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2024. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:55 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 730 | $24.48 | $17,866.75 |
DisclosureSEC source: 0001127602-25-011936 · form4.xml · nonDerivative · entry 2 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,449 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:55 UTC |
Hui YvonnePrincipal Accounting Officer
|
SaleCommon Stock | 1,148 | $23.46 | $26,928.41 |
DisclosureSEC source: 0001127602-25-011936 · form4.xml · nonDerivative · entry 1 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,179 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:59 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 96 | $24.48 | $2,349.60 |
DisclosureSEC source: 0001127602-25-011940 · form4.xml · nonDerivative · entry 4 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,012 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:59 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 152 | $23.46 | $3,565.43 |
DisclosureSEC source: 0001127602-25-011940 · form4.xml · nonDerivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,108 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:59 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 1,534 | $24.48 | $37,544.65 |
DisclosureSEC source: 0001127602-25-011940 · form4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,738 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:59 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 2,410 | $23.46 | $56,530.89 |
DisclosureSEC source: 0001127602-25-011940 · form4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,272 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:58 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 4,733 | $24.48 | $115,840.18 |
DisclosureSEC source: 0001127602-25-011939 · form4.xml · nonDerivative · entry 2 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,257,665 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:58 UTC |
Indig ChaimDirector · Chief Executive Officer
|
SaleCommon Stock | 7,434 | $23.46 | $174,377.85 |
DisclosureSEC source: 0001127602-25-011939 · form4.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,262,398 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:57 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 659 | $24.48 | $16,129.03 |
DisclosureSEC source: 0001127602-25-011938 · form4.xml · nonDerivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,444 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:57 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 1,036 | $23.46 | $24,301.24 |
DisclosureSEC source: 0001127602-25-011938 · form4.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,103 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:55 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 2,343 | $24.48 | $57,344.93 |
DisclosureSEC source: 0001127602-25-011935 · form4.xml · nonDerivative · entry 2 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,830 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:55 UTC |
Hoffman Allison CGeneral Counsel & Secretary
|
SaleCommon Stock | 3,681 | $23.46 | $86,344.48 |
DisclosureSEC source: 0001127602-25-011935 · form4.xml · nonDerivative · entry 1 Hoffman Allison C · CIK 0001564521 · General Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,173 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:56 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 2,813 | $24.48 | $68,848.18 |
DisclosureSEC source: 0001127602-25-011937 · form4.xml · nonDerivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 776,652 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:56 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 4,420 | $23.46 | $103,679.06 |
DisclosureSEC source: 0001127602-25-011937 · form4.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 779,465 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:53 UTC |
Gandhi BalajiChief Financial Officer
|
SaleCommon Stock | 3,129 | $24.48 | $76,582.28 |
DisclosureSEC source: 0001127602-25-011934 · form4.xml · nonDerivative · entry 2 Gandhi Balaji · CIK 0001970527 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,411 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2025 Filed Apr 11, 2025 00:53 UTC |
Gandhi BalajiChief Financial Officer
|
SaleCommon Stock | 4,916 | $23.46 | $115,313.63 |
DisclosureSEC source: 0001127602-25-011934 · form4.xml · nonDerivative · entry 1 Gandhi Balaji · CIK 0001970527 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,540 F1 · kind: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.995 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 23:25 UTC |
Hui YvonnePrincipal Accounting Officer
|
GrantCommon Stock | 4,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011834 · form4.xml · nonDerivative · entry 1 Hui Yvonne · CIK 0002027089 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,327 F1 · price: Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 23:06 UTC |
Linetsky DavidSVP, Life Sciences
|
GrantCommon Stock | 536 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011830 · form4.xml · nonDerivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 9,260 F3 · price: Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 23:06 UTC |
Linetsky DavidSVP, Life Sciences
|
GrantCommon Stock | 6,432 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011830 · form4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,682 F3 · price: Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025. F2 · balance_after: The total in Column 5 has been adjusted to correct an overstatement of holdings by 2,298 shares first reflected in a Form 4 filed on May 5, 2021. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 23:31 UTC |
Gandhi BalajiChief Financial Officer
|
GrantCommon Stock | 12,865 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011836 · form4.xml · nonDerivative · entry 1 Gandhi Balaji · CIK 0001970527 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,456 F1 · price: Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of the Reporting Person's cash bonus earned for the fiscal year ending January 31, 2025 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $24.31, the closing price of the Issuer's common stock on April 4, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.